{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2010 sorted by posted_date descending", "rows": [["FDA-2010-N-0118-0005", "FDA", "FDA-2010-N-0118", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Imported Food under 2002 Public Health Security and Bioterrorism Preparedness and Response Act of 2002", "Notice", "N-Notice", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2010-12-30T14:44:54Z", "2010-32946", 0, 0, "0900006480bc26ef"], ["FDA-2010-N-0356-0004", "FDA", "FDA-2010-N-0356", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Designated New Animal Drugs for Minor Use and Minor Species", "Notice", "N-Notice", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2010-12-30T14:39:28Z", "2010-32948", 0, 0, "0900006480bc26eb"], ["FDA-2010-N-0001-0163", "FDA", "FDA-2010-N-0001", "Meetings: Pulmonary-Allergy Drugs Advisory Committee", "Notice", "NM-Notice of Meeting", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2010-12-29T15:23:00Z", "2010-32735", 0, 0, "0900006480bc1b9a"], ["FDA-2010-N-0640-0001", "FDA", "FDA-2010-N-0640", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Data To Support Food and Nutrition Product Communications, as Used by Food and Drug Administration", "Notice", "N-Notice", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", "2011-03-01T04:59:59Z", "2010-12-29T15:29:12Z", "2010-32739", 0, 0, "0900006480bc1bc0"], ["FDA-2010-N-0198-0003", "FDA", "FDA-2010-N-0198", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Premarket Notification", "Notice", "N-Notice", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T16:44:38Z", "2010-32508", 0, 0, "0900006480bc11ca"], ["FDA-2010-P-0326-0003", "FDA", "FDA-2010-P-0326", "Determination that Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness: TRANDATE (Labetalol Hydrochloride) Tablets, 300 Milligrams and 400 Milligrams", "Notice", "N-Notice", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T16:37:57Z", "2010-32507", 0, 0, "0900006480bc11ac"], ["FDA-2010-N-0001-0161", "FDA", "FDA-2010-N-0001", "Meetings: Anesthetic and Life Support Drugs Advisory Committee", "Notice", "NM-Notice of Meeting", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T16:11:53Z", "2010-32591", 0, 0, "0900006480bc0c47"], ["FDA-2010-N-0001-0162", "FDA", "FDA-2010-N-0001", "Request for Nominations: Voting and Non-Voting Members of Public Advisory Committees or Panels", "Notice", "N-Notice", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T16:28:32Z", "2010-32624", 0, 0, "0900006480bc1153"], ["FDA-2010-N-0447-0003", "FDA", "FDA-2010-N-0447", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Third Party Review Program Under the Food and Drug Administration Modernization Act", "Notice", "N-Notice", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2011-03-14T20:37:01Z", "2010-32603", 0, 0, "0900006480bc0c82"], ["FDA-2010-N-0001-0160", "FDA", "FDA-2010-N-0001", "Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2010-12-27T14:48:01Z", "2010-32367", 0, 0, "0900006480bc03c3"], ["FDA-2010-N-0001-0159", "FDA", "FDA-2010-N-0001", "Oncologic Drugs Advisory Committee; Cancellation", "Notice", "N-Notice", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2010-12-27T14:44:55Z", "2010-32413", 0, 0, "0900006480bc0306"], ["FDA-2010-D-0575-0001", "FDA", "FDA-2010-D-0575", "Draft Compliance Policy Guide Sec. 510.800 Beverages, Serving Size Labeling; Availability", "Notice", "NAD-Notice of Availability of Data", "2010-12-23T05:00:00Z", 2010, 12, "2010-12-23T05:00:00Z", "2011-02-23T04:59:59Z", "2010-12-23T14:41:09Z", "2010-32249", 0, 0, "0900006480bbe9be"], ["FDA-2010-N-0266-0007", "FDA", "FDA-2010-N-0266", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Study of Clinical Efficacy Information in Professional Labeling, etc.; Correction", "Notice", "NCR-Notice of Correction", "2010-12-23T05:00:00Z", 2010, 12, "2010-12-23T05:00:00Z", null, "2010-12-23T15:27:48Z", "2010-32278", 0, 0, "0900006480bbea66"], ["FDA-2010-N-0631-0001", "FDA", "FDA-2010-N-0631", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry on Updating Labeling for Susceptibility Test Information in Systemic Antibacterial Drug Products, etc.", "Notice", "N-Notice", "2010-12-23T05:00:00Z", 2010, 12, "2010-12-23T05:00:00Z", "2011-02-23T04:59:59Z", "2010-12-23T15:30:54Z", "2010-32276", 0, 0, "0900006480bbea69"], ["FDA-2009-D-0466-0008", "FDA", "FDA-2009-D-0466", "Compliance Policy Guide; Dairy Products; Availability: Microbial Contaminants and Alkaline Phosphatase Activity", "Notice", "NAD-Notice of Availability of Data", "2010-12-23T05:00:00Z", 2010, 12, "2010-12-23T05:00:00Z", null, "2024-11-07T22:30:06Z", "2010-32232", 1, 0, "0900006480bbe9e4"], ["FDA-2010-N-0074-0003", "FDA", "FDA-2010-N-0074", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments, etc.", "Notice", "N-Notice", "2010-12-23T05:00:00Z", 2010, 12, "2010-12-23T05:00:00Z", null, "2010-12-23T14:16:46Z", "2010-32277", 0, 0, "0900006480bbe9b2"], ["FDA-2010-N-0368-0007", "FDA", "FDA-2010-N-0368", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Pet Event Tracking Network -- State, Federal Cooperation to Prevent Spread of Pet Food Related Diseases", "Notice", "N-Notice", "2010-12-23T05:00:00Z", 2010, 12, "2010-12-23T05:00:00Z", "2011-01-25T04:59:59Z", "2010-12-23T14:34:11Z", "2010-32275", 0, 0, "0900006480bbe9b3"], ["FDA-2004-D-0298-0005", "FDA", "FDA-2004-D-0298", "Compliance Policy Guides: Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs", "Notice", "NEC-Notice of Extension", "2010-12-23T05:00:00Z", 2010, 12, "2010-12-23T05:00:00Z", null, "2024-11-07T22:30:10Z", "2010-32274", 1, 0, "0900006480bbea44"], ["FDA-2010-N-0001-0158", "FDA", "FDA-2010-N-0001", "Meetings: Advisory Committees; Tentative Schedule for 2011", "Notice", "N-Notice", "2010-12-21T05:00:00Z", 2010, 12, "2010-12-21T05:00:00Z", null, "2010-12-21T14:54:16Z", "2010-31961", 0, 0, "0900006480bbcc5e"], ["FDA-2010-N-0626-0001", "FDA", "FDA-2010-N-0626", "Abbott Laboratories, Inc.; Withdrawal of Approval of a New Drug Application for MERIDIA", "Notice", "Withdrawal", "2010-12-21T05:00:00Z", 2010, 12, null, null, "2018-02-26T16:00:33Z", "2010-31986", 0, 0, "0900006480bbcc3f"], ["FDA-2010-E-0042-0005", "FDA", "FDA-2010-E-0042", "Regulatory Review Periods for Purposes of Patent Extensions; Determinations: LIVALO", "Notice", "N-Notice", "2010-12-20T05:00:00Z", 2010, 12, "2010-12-20T05:00:00Z", "2011-02-19T04:59:59Z", "2010-12-20T16:01:56Z", "2010-31847", 0, 0, "0900006480bba8e1"], ["FDA-2010-N-0420-0004", "FDA", "FDA-2010-N-0420", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Testing Communications on FDA-Regulated Products Used in Animals", "Notice", "N-Notice", "2010-12-20T05:00:00Z", 2010, 12, "2010-12-20T05:00:00Z", "2011-01-20T04:59:59Z", "2010-12-20T15:38:33Z", "2010-31891", 0, 0, "0900006480bba849"], ["FDA-2010-N-0528-0001", "FDA", "FDA-2010-N-0528", "Unapproved Animal Drugs", "Notice", "N-Notice", "2010-12-20T05:00:00Z", 2010, 12, "2010-12-20T05:00:00Z", "2011-02-19T04:59:59Z", "2010-12-20T15:22:13Z", "2010-31889", 0, 0, "0900006480bba831"], ["FDA-2010-E-0030-0005", "FDA", "FDA-2010-E-0030", "Regulatory Review Periods for Purposes of Patent Extensions; Determinations: FOLOTYN", "Notice", "N-Notice", "2010-12-20T05:00:00Z", 2010, 12, "2010-12-20T05:00:00Z", "2011-02-19T04:59:59Z", "2010-12-20T15:54:26Z", "2010-31846", 0, 0, "0900006480bba892"], ["FDA-2010-N-0001-0157", "FDA", "FDA-2010-N-0001", "Meetings: Defense Advanced Research Projects Agency and Food and Drug Administration Expanding in Vivo Biomarker Detection Devices Workshop", "Notice", "NM-Notice of Meeting", "2010-12-20T05:00:00Z", 2010, 12, "2010-12-20T05:00:00Z", null, "2010-12-20T15:47:37Z", "2010-31811", 0, 0, "0900006480bba880"], ["FDA-2010-N-0627-0001", "FDA", "FDA-2010-N-0627", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Application for Food and Drug Administration Approval to Market New Drug", "Notice", "N-Notice", "2010-12-17T05:00:00Z", 2010, 12, "2010-12-17T05:00:00Z", "2011-02-16T04:59:59Z", "2010-12-17T14:36:03Z", "2010-31693", 0, 0, "0900006480bb91f0"], ["FDA-2010-N-0235-0001", "FDA", "FDA-2010-N-0235", "Debarment Orders: Ehigiator O. Akhigbe", "Notice", "NFR-Notice of Final Rule", "2010-12-17T05:00:00Z", 2010, 12, "2010-12-17T05:00:00Z", null, "2010-12-17T14:31:06Z", "2010-31776", 0, 0, "0900006480bb919d"], ["FDA-2010-D-0605-0001", "FDA", "FDA-2010-D-0605", "Small Entity Compliance Guides; Availability, etc.: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements", "Notice", "NAD-Notice of Availability of Data", "2010-12-16T05:00:00Z", 2010, 12, "2010-12-16T05:00:00Z", null, "2024-11-12T05:00:25Z", "2010-31613", 1, 0, "0900006480bb8272"], ["FDA-2001-E-0027-0020", "FDA", "FDA-2001-E-0027", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: ANGIOMAX", "Notice", "N-Notice", "2010-12-16T05:00:00Z", 2010, 12, "2010-12-16T05:00:00Z", null, "2024-11-12T05:00:23Z", "2010-31583", 1, 0, "0900006480bb825a"], ["FDA-2010-D-0616-0001", "FDA", "FDA-2010-D-0616", "Draft Guidance for Industry; Availability: Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination", "Notice", "NAD-Notice of Availability of Data", "2010-12-15T05:00:00Z", 2010, 12, "2010-12-15T05:00:00Z", "2011-02-15T04:59:59Z", "2010-12-15T22:26:14Z", "2010-31426", 0, 0, "0900006480bb7048"], ["FDA-2010-N-0184-0007", "FDA", "FDA-2010-N-0184", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study of Patient Information Prototypes", "Notice", "NAD-Notice of Availability of Data", "2010-12-15T05:00:00Z", 2010, 12, "2010-12-15T05:00:00Z", "2011-01-15T04:59:59Z", "2010-12-15T21:58:54Z", "2010-31388", 0, 0, "0900006480bb7010"], ["FDA-2010-N-0623-0001", "FDA", "FDA-2010-N-0623", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Voluntary Cosmetic Registration Program", "Notice", "N-Notice", "2010-12-15T05:00:00Z", 2010, 12, "2010-12-15T05:00:00Z", "2011-02-15T04:59:59Z", "2010-12-15T22:04:45Z", "2010-31386", 0, 0, "0900006480bb7013"], ["FDA-2009-D-0008-0009", "FDA", "FDA-2009-D-0008", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry on Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of Federal Food, Drug, and Cosmetic Act", "Notice", "N-Notice", "2010-12-15T05:00:00Z", 2010, 12, null, null, "2010-12-15T22:16:59Z", "2010-31380", 0, 0, "0900006480bb70ec"], ["FDA-2010-N-0380-0002", "FDA", "FDA-2010-N-0380", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Food and Drug Administration Rapid Response Surveys", "Notice", "N-Notice", "2010-12-15T05:00:00Z", 2010, 12, "2010-12-15T05:00:00Z", "2011-01-15T04:59:59Z", "2010-12-15T21:54:50Z", "2010-31381", 0, 0, "0900006480bb6f22"], ["FDA-2009-N-0360-0003", "FDA", "FDA-2009-N-0360", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Public Health Notification Readership Survey", "Notice", "N-Notice", "2010-12-15T05:00:00Z", 2010, 12, null, null, "2010-12-15T22:09:18Z", "2010-31387", 0, 0, "0900006480bb7067"], ["FDA-2010-N-0418-0003", "FDA", "FDA-2010-N-0418", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Institutional Review Boards", "Notice", "N-Notice", "2010-12-15T05:00:00Z", 2010, 12, null, null, "2010-12-15T22:13:12Z", "2010-31389", 0, 0, "0900006480bb70a6"], ["FDA-2010-E-0038-0005", "FDA", "FDA-2010-E-0038", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: SAMSCA", "Notice", "N-Notice", "2010-12-14T05:00:00Z", 2010, 12, "2010-12-14T05:00:00Z", null, "2010-12-14T20:35:51Z", "2010-31298", 0, 0, "0900006480bb6397"], ["FDA-2009-E-0014-0006", "FDA", "FDA-2009-E-0014", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: FREESTYLE NAVIGATOR", "Notice", "N-Notice", "2010-12-14T05:00:00Z", 2010, 12, "2010-12-14T05:00:00Z", null, "2010-12-14T20:43:14Z", "2010-31240", 0, 0, "0900006480bb5eeb"], ["FDA-2010-E-0024-0005", "FDA", "FDA-2010-E-0024", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: VIBATIV", "Notice", "N-Notice", "2010-12-14T05:00:00Z", 2010, 12, "2010-12-14T05:00:00Z", null, "2010-12-14T19:45:10Z", "2010-31250", 0, 0, "0900006480bb6337"], ["FDA-2010-E-0022-0005", "FDA", "FDA-2010-E-0022", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: VIBATIV", "Notice", "N-Notice", "2010-12-14T05:00:00Z", 2010, 12, "2010-12-14T05:00:00Z", null, "2010-12-14T19:17:04Z", "2010-31250", 0, 0, "0900006480bb5ecf"], ["FDA-2010-N-0618-0001", "FDA", "FDA-2010-N-0618", "Statements of Organization, Functions and Delegations of Authority", "Notice", "N-Notice", "2010-12-14T05:00:00Z", 2010, 12, null, null, "2010-12-15T22:21:20Z", "2010-31383", 0, 0, "0900006480bb70c2"], ["FDA-2010-E-0037-0005", "FDA", "FDA-2010-E-0037", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: SAMSCA", "Notice", "N-Notice", "2010-12-14T05:00:00Z", 2010, 12, "2010-12-14T05:00:00Z", null, "2010-12-14T16:49:55Z", "2010-31298", 0, 0, "0900006480bb5ebd"], ["FDA-2010-N-0622-0001", "FDA", "FDA-2010-N-0622", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Color Additive Certification Requests and Recordkeeping", "Notice", "60 Day Proposed Information Collection", "2010-12-13T05:00:00Z", 2010, 12, "2010-12-13T05:00:00Z", "2011-02-12T04:59:59Z", "2017-03-17T14:13:33Z", "2010-31195", 0, 0, "0900006480bb4ff1"], ["FDA-1976-N-0111-0001", "FDA", "FDA-1976-N-0111", "Food and Drug Administration, Department of Health, Education, and Welfare; Recodification Editorial and Technical Amendments", "Notice", "N-Notice", "2010-12-13T05:00:00Z", 2010, 12, "2010-12-13T05:00:00Z", null, "2010-12-13T23:14:26Z", null, 0, 0, "090000648051dacf"], ["FDA-2010-N-0389-0017", "FDA", "FDA-2010-N-0389", "Meetings: Medical Device User Fee Program; Request for Notification of Patientand Consumer Advocacy Group Intentions to Participate", "Notice", "N-Notice", "2010-12-13T05:00:00Z", 2010, 12, "2010-12-13T05:00:00Z", null, "2010-12-13T15:25:18Z", "2010-31160", 0, 0, "0900006480bb4fc1"], ["FDA-2010-E-0040-0006", "FDA", "FDA-2010-E-0040", "Deteermination of Regulatory Review Period for Purposes of Patent Extension; MULTAQ", "Notice", "N-Notice", "2010-12-10T05:00:00Z", 2010, 12, "2010-12-10T05:00:00Z", null, "2010-12-10T16:25:59Z", null, 0, 0, "0900006480bb3d90"], ["FDA-2010-N-0001-0156", "FDA", "FDA-2010-N-0001", "Tobacco Products Scientific Advisory Committee; Notice of Meeting", "Notice", "GDL-Guidance", "2010-12-10T05:00:00Z", 2010, 12, "2010-12-10T05:00:00Z", null, "2010-12-10T16:30:50Z", "2010-31066", 0, 0, "0900006480bb392a"], ["FDA-2005-D-0072-0005", "FDA", "FDA-2005-D-0072", "Guidance for Public, FDA Advisory Committee Members, and FDA Staff; Availability: The Open Public Hearing at FDA Advisory Committee Meetings;Availability", "Notice", "NAD-Notice of Availability of Data", "2010-12-10T05:00:00Z", 2010, 12, "2010-12-10T05:00:00Z", null, "2024-11-07T22:28:26Z", "2010-31022", 1, 0, "0900006480bb387e"], ["FDA-2009-E-0510-0012", "FDA", "FDA-2009-E-0510", "Determination of Regulatory Review Period for Purposes of Patent Extension: COARTEM", "Notice", "N-Notice", "2010-12-10T05:00:00Z", 2010, 12, "2010-12-10T05:00:00Z", null, "2024-11-07T22:28:12Z", "2010-31074", 1, 0, "0900006480bb3967"], ["FDA-2010-E-0039-0006", "FDA", "FDA-2010-E-0039", "Determination of Regulatory Review Period for Purposes of Patent Extension: MULTAQ", "Notice", "N-Notice", "2010-12-10T05:00:00Z", 2010, 12, "2010-12-10T05:00:00Z", null, "2010-12-10T16:20:27Z", "2010-31064", 0, 0, "0900006480bb389f"], ["FDA-2010-E-0021-0005", "FDA", "FDA-2010-E-0021", "Determinations of Regulatory Review Periods for Purposes of Patent Extension; SABRIL", "Notice", "N-Notice", "2010-12-09T05:00:00Z", 2010, 12, "2010-12-09T05:00:00Z", null, "2024-11-07T22:27:57Z", "2010-30995", 1, 0, "0900006480bb2d85"], ["FDA-2010-E-0044-0005", "FDA", "FDA-2010-E-0044", "Determinations of Regulatory Review Periods for Purposes of Patent Extension; BEPREVE", "Notice", "N-Notice", "2010-12-09T05:00:00Z", 2010, 12, "2010-12-09T05:00:00Z", null, "2024-11-07T22:28:14Z", "2010-30991", 1, 0, "0900006480bb2846"], ["FDA-2010-E-0047-0003", "FDA", "FDA-2010-E-0047", "Determination of Regulatory Review Period for Purposes of Patent Extension; ILARIS", "Notice", "N-Notice", "2010-12-09T05:00:00Z", 2010, 12, "2010-12-09T05:00:00Z", null, "2024-11-07T22:27:57Z", "2010-30992", 1, 0, "0900006480bb2d66"], ["FDA-2010-P-0177-0004", "FDA", "FDA-2010-P-0177", "Determination That AUGMENTIN \u2018125\u2019 (Amoxicillin; Clavulanate Potassium) Chewable Tablet and Six Other AUGMENTIN (Amoxicillin; Clavulanate Potassium) Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "N-Notice", "2010-12-08T05:00:00Z", 2010, 12, "2010-12-08T05:00:00Z", null, "2010-12-08T16:13:47Z", "2010-30622", 0, 0, "0900006480bb20d9"], ["FDA-2010-N-0602-0001", "FDA", "FDA-2010-N-0602", "Biologies Price Competition and Innovation Act of 2009;Meetings: User Fee Program for Biosimilar and Interchangeable Biological Product Applications; Request for Notification of Stakeholer Intention to Participate", "Notice", "N-Notice", "2010-12-08T05:00:00Z", 2010, 12, "2010-12-08T05:00:00Z", "2011-01-11T04:59:59Z", "2010-12-08T16:09:30Z", "2010-30713", 0, 0, "0900006480bb1e4f"], ["FDA-2010-N-0088-0003", "FDA", "FDA-2010-N-0088", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Electronic Products; General Requirements", "Notice", "NAL-Notice of Approval", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", null, "2010-12-08T14:17:25Z", "2010-30555", 0, 0, "0900006480bb0cf7"], ["FDA-2010-N-0568-0006", "FDA", "FDA-2010-N-0568", "Required Warnings for Cigarette Packages and Advertisements; Research Report", "Notice", "N-Notice", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", "2011-01-12T04:59:59Z", "2011-06-11T16:29:00Z", "2010-30685", 0, 0, "0900006480bb0be7"], ["FDA-2010-P-0172-0005", "FDA", "FDA-2010-P-0172", "Determinations that Drug Products Not Withdrawn from Sale for Reasons of Safety or Effectiveness: AUGMENTIN 125 (Amoxicillin; Clavulanate Potassium) Chewable Tablet and Six Other AUGMENTIN (Amoxicillin; Clavulanate Potassium)", "Notice", "N-Notice", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", null, "2010-12-07T17:42:31Z", "2010-30622", 0, 0, "0900006480bb0c74"], ["FDA-2010-N-0551-0001", "FDA", "FDA-2010-N-0551", "Compliance Policy Guides; Withdrawals: Laser(s) as Medical Devices for Facelift, Wrinkle Removal, Acupuncture, Auricular Stimulation, etc.", "Notice", "NWL-Notice of Withdrawl", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", null, "2010-12-07T16:06:30Z", "2010-30679", 0, 0, "0900006480bb0c03"], ["FDA-2010-N-0316-0002", "FDA", "FDA-2010-N-0316", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Adverse Event Pilot Program for Medical Products", "Notice", "N-Notice", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", "2011-01-07T04:59:59Z", "2010-12-07T16:43:53Z", "2010-30583", 0, 0, "0900006480bb0c2a"], ["FDA-2010-N-0550-0001", "FDA", "FDA-2010-N-0550", "Withdrawals Of Guidance: Compliance Policy Guide Sec. 390.500 Definition of High-Voltage Vacuum Switch", "Notice", "NWL-Notice of Withdrawl", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", null, "2010-12-08T13:59:45Z", "2010-30677", 0, 0, "0900006480bb0caf"], ["FDA-2010-N-0001-0154", "FDA", "FDA-2010-N-0001", "Meetings: Third Annual Sentinel Initiative; Public Workshop", "Notice", "NM-Notice of Meeting", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", null, "2010-12-08T14:06:32Z", "2010-30562", 0, 0, "0900006480bb0c93"], ["FDA-2010-P-0275-0003", "FDA", "FDA-2010-P-0275", "Determinations that Product Withdrawal From Sale Was Not for Reasons of Safety or Effectiveness: GLEEVEC (Imatinib Mesylate) Capsules, 50 Milligrams and 100 Milligrams", "Notice", "N-Notice", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", null, "2010-12-07T15:24:43Z", "2010-30570", 0, 0, "0900006480bb0be6"], ["FDA-2004-N-0056-0012", "FDA", "FDA-2004-N-0056", "Annual Guidance Agenda - Notice", "Notice", "N-Notice", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", null, "2011-01-19T13:30:11Z", "2010-30623", 0, 0, "0900006480bb0c04"], ["FDA-2010-N-0606-0001", "FDA", "FDA-2010-N-0606", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Additional Listing Information for Medical Device Registration and Listing", "Notice", "N-Notice", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", "2011-02-08T04:59:59Z", "2010-12-08T14:31:55Z", "2010-30582", 0, 0, "0900006480bb0c5c"], ["FDA-2010-N-0083-0004", "FDA", "FDA-2010-N-0083", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Substances Prohibited From Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed", "Notice", "NAL-Notice of Approval", "2010-12-07T05:00:00Z", 2010, 12, "2010-12-07T05:00:00Z", null, "2010-12-08T14:20:57Z", "2010-30556", 0, 0, "0900006480bb0c4c"], ["FDA-2010-N-0001-0152", "FDA", "FDA-2010-N-0001", "Meetings: Oncologic Drugs Advisory Committee", "Notice", "NM-Notice of Meeting", "2010-12-06T05:00:00Z", 2010, 12, "2010-12-06T05:00:00Z", null, "2010-12-06T16:46:45Z", "2010-30502", 0, 0, "0900006480bafeac"], ["FDA-2000-N-0163-0023", "FDA", "FDA-2000-N-0163", "Reclassifications of Category IIIA Biological Products, Bacterial Vaccines and Related Biological Products, etc.: Delmont Laboratories, Inc.; Denial of Request for Hearing and Revocation of License", "Notice", "NFR-Notice of Final Rule", "2010-12-06T05:00:00Z", 2010, 12, "2010-12-06T05:00:00Z", null, "2010-12-06T17:22:07Z", "2010-30441", 0, 0, "0900006480bafeaf"], ["FDA-2009-E-0584-0005", "FDA", "FDA-2009-E-0584", "Determination of Regulatory Review Period for Purposes of Patent Extension: Besivance", "Notice", "N-Notice", "2010-12-06T05:00:00Z", 2010, 12, "2010-12-06T05:00:00Z", null, "2010-12-08T16:21:28Z", "2010-30510", 0, 0, "0900006480baff29"], ["FDA-2010-N-0595-0001", "FDA", "FDA-2010-N-0595", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Exports; Notification and Recordkeeping Requirements", "Notice", "N-Notice", "2010-12-06T05:00:00Z", 2010, 12, "2010-12-06T05:00:00Z", "2011-02-05T04:59:59Z", "2010-12-06T16:36:03Z", "2010-30433", 0, 0, "0900006480bafe8a"], ["FDA-2010-E-0036-0004", "FDA", "FDA-2010-E-0036", "Determination of Regulatory Review Period for Purposes of Patent Extension; STELARA", "Notice", "N-Notice", "2010-12-06T05:00:00Z", 2010, 12, "2010-12-06T05:00:00Z", null, "2010-12-06T20:53:16Z", "2010-30512", 0, 0, "0900006480bafc54"], ["FDA-2010-E-0032-0004", "FDA", "FDA-2010-E-0032", "Determination of Regulatory Review Period for Purposes of Patent Extension: Stelara", "Notice", "N-Notice", "2010-12-06T05:00:00Z", 2010, 12, "2010-12-06T05:00:00Z", null, "2010-12-06T17:40:07Z", "2010-30512", 0, 0, "0900006480baff07"], ["FDA-2010-N-0001-0153", "FDA", "FDA-2010-N-0001", "Meetings: Peripheral and Central Nervous System Drugs Advisory Committee", "Notice", "NM-Notice of Meeting", "2010-12-06T05:00:00Z", 2010, 12, "2010-12-06T05:00:00Z", null, "2010-12-06T17:28:55Z", "2010-30501", 0, 0, "0900006480bafed0"], ["FDA-2009-D-0137-0025", "FDA", "FDA-2009-D-0137", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry; Use of Serological Tests to Reduce Risk of Transmission of Trypanosoma cruzi Infection, etc.", "Notice", "30 Day Proposed Information Collection", "2010-12-06T05:00:00Z", 2010, 12, "2010-12-06T05:00:00Z", "2011-01-06T04:59:59Z", "2016-10-28T18:34:06Z", "2010-30404", 0, 0, "0900006480bafe83"], ["FDA-2009-D-0137-0026", "FDA", "FDA-2009-D-0137", "Guidance for Industry: Use of Serological Tests to Reduce Riskof Transmission of Trypanosoma cruzi Infection, etc.", "Notice", "Notice of Availability", "2010-12-06T05:00:00Z", 2010, 12, "2010-12-06T05:00:00Z", null, "2016-10-28T18:39:30Z", "2010-30405", 0, 0, "0900006480baff0b"], ["FDA-2009-D-0533-0008", "FDA", "FDA-2009-D-0533", "Guidance for Industry:  Recommendations for Blood Establishments; Availability: Training of Back-UpPersonnel, Assessment of Blood Donor Suitability, and Reporting Certain Changes to an Approved Application", "Notice", "NAD-Notice of Availability of Data", "2010-12-03T05:00:00Z", 2010, 12, "2010-12-03T05:00:00Z", null, "2010-12-03T19:53:33Z", "2010-30388", 0, 0, "0900006480bad6f5"], ["FDA-1999-F-0056-0003", "FDA", "FDA-1999-F-0056", "National Fisheries Institute; Filing of Food Additive Petition (FAP 9M4682)", "Notice", "NFL-Notice of Filing", "2010-12-03T05:00:00Z", 2010, 12, "2010-12-03T05:00:00Z", null, "2010-12-03T17:37:36Z", null, 0, 0, "09000064804a61c6"], ["FDA-2010-D-0566-0001", "FDA", "FDA-2010-D-0566", "Draft Guidance for Industry on Residual Solvents in Animal Drug Products; Questions and Answers;Availability", "Notice", "NAD-Notice of Availability of Data", "2010-12-03T05:00:00Z", 2010, 12, "2010-12-03T05:00:00Z", "2011-02-02T04:59:59Z", "2010-12-03T17:35:27Z", "2010-30387", 0, 0, "0900006480bad670"], ["FDA-2010-N-0597-0001", "FDA", "FDA-2010-N-0597", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Index of Legally Marketed Unapproved New Animal Drugs for Minor Species", "Notice", "60 Day Proposed Information Collection", "2010-12-03T05:00:00Z", 2010, 12, "2010-12-03T05:00:00Z", "2011-02-02T04:59:59Z", "2016-12-08T14:14:19Z", "2010-30335", 0, 0, "0900006480bad543"], ["FDA-2010-N-0266-0005", "FDA", "FDA-2010-N-0266", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Study of ClinicalEfficacy Information in Professional Labeling and Direct-to-Consumer Print Advertisements for Prescription Drugs", "Notice", "N-Notice", "2010-12-03T05:00:00Z", 2010, 12, "2010-12-03T05:00:00Z", "2011-01-04T04:59:59Z", "2010-12-03T17:25:33Z", "2010-30385", 0, 0, "0900006480bad6f4"], ["FDA-2010-N-0001-0151", "FDA", "FDA-2010-N-0001", "Meetings: Gastrointestinal Drugs Advisory Committee", "Notice", "NM-Notice of Meeting", "2010-12-02T05:00:00Z", 2010, 12, "2010-12-02T05:00:00Z", null, "2010-12-02T18:04:06Z", "2010-30274", 0, 0, "0900006480babfeb"], ["FDA-2010-N-0603-0001", "FDA", "FDA-2010-N-0603", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Animal Drug User Fees and Fee Waivers and Reductions", "Notice", "N-Notice", "2010-12-02T05:00:00Z", 2010, 12, "2010-12-02T05:00:00Z", "2011-02-01T04:59:59Z", "2010-12-02T17:58:10Z", "2010-30264", 0, 0, "0900006480bac029"], ["FDA-2010-N-0182-0003", "FDA", "FDA-2010-N-0182", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Procedures for Safe and Sanitary Processing and Importing of Fish and Fishery Products", "Notice", "NAL-Notice of Approval", "2010-12-02T05:00:00Z", 2010, 12, "2010-12-02T05:00:00Z", null, "2010-12-02T17:53:36Z", "2010-30277", 0, 0, "0900006480babf74"], ["FDA-2010-N-0001-0149", "FDA", "FDA-2010-N-0001", "Food Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2010-12-01T05:00:00Z", 2010, 12, null, null, "2011-08-16T19:06:57Z", "2010-30187", 0, 0, "0900006480baaef2"], ["FDA-2010-N-0001-0150", "FDA", "FDA-2010-N-0001", "Workshops: Food Labeling", "Notice", "NM-Notice of Meeting", "2010-12-01T05:00:00Z", 2010, 12, "2010-12-01T05:00:00Z", null, "2010-12-01T20:48:06Z", "2010-30191", 0, 0, "0900006480baaf41"], ["FDA-2010-N-0576-0001", "FDA", "FDA-2010-N-0576", "Requests for Supplemental Applications: Supplemental Funding under Food and Drug Administration'sConvener of Active Medical Product Surveillance Discussions", "Notice", "NI-Notice of Intent", "2010-11-30T05:00:00Z", 2010, 11, "2010-11-30T05:00:00Z", null, "2010-11-30T17:35:37Z", "2010-30054", 0, 0, "0900006480ba953e"], ["FDA-2010-M-0519-0002", "FDA", "FDA-2010-M-0519", "Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval", "Notice", "NAL-Notice of Approval", "2010-11-30T05:00:00Z", 2010, 11, "2010-11-30T05:00:00Z", null, "2010-11-30T17:29:06Z", null, 0, 0, "0900006480ba9673"], ["FDA-1996-M-0183-0001", "FDA", "FDA-1996-M-0183", "Home Access Health Corp.; Premarket Approval of the Home Access HIV-1 Test System", "Notice", "NAL-Notice of Approval", "2010-11-30T05:00:00Z", 2010, 11, "2010-11-30T05:00:00Z", null, "2010-11-30T18:48:05Z", null, 0, 0, "0900006480500b9a"], ["FDA-2010-N-0594-0001", "FDA", "FDA-2010-N-0594", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Focus Groups as Usedby Food and Drug Administration (All Food and Drug Administration Regulated Products)", "Notice", "N-Notice", "2010-11-30T05:00:00Z", 2010, 11, "2010-11-30T05:00:00Z", "2011-02-01T04:59:59Z", "2010-11-30T16:28:27Z", "2010-30037", 0, 0, "0900006480ba9035"], ["FDA-2010-N-0588-0001", "FDA", "FDA-2010-N-0588", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Exceptions or Alternatives to Labeling Requirements for Products Held by Strategic National Stockpile", "Notice", "N-Notice", "2010-11-30T05:00:00Z", 2010, 11, "2010-11-30T05:00:00Z", "2011-02-01T04:59:59Z", "2020-10-06T19:47:38Z", "2010-30036", 0, 0, "0900006480ba953f"], ["FDA-2010-N-0583-0001", "FDA", "FDA-2010-N-0583", "Agency Information Collection Activities: Proposed Collection;\nComment Request; Radioactive Drug Research Committees", "Notice", "60 Day Proposed Information Collection", "2010-11-30T05:00:00Z", 2010, 11, "2010-11-30T05:00:00Z", "2011-02-01T04:59:59Z", "2015-03-09T12:22:51Z", "2010-30038", 0, 0, "0900006480ba90d1"], ["FDA-2010-D-0589-0001", "FDA", "FDA-2010-D-0589", "Draft Guidance for Industry on Hospital-Acquired Bacterial  Pneumonia and Ventilator-Associated Bacterial Pneumonia: Developing Drugs for Treatment; Availability", "Notice", "NAD-Notice of Availability of Data", "2010-11-29T05:00:00Z", 2010, 11, "2010-11-29T05:00:00Z", "2011-03-01T04:59:59Z", "2011-03-10T20:37:20Z", "2010-29799", 0, 0, "0900006480ba7c22"], ["FDA-2010-N-0600-0001", "FDA", "FDA-2010-N-0600", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Animal Drug User Fee Cover Sheet", "Notice", "60 Day Proposed Information Collection", "2010-11-29T05:00:00Z", 2010, 11, "2010-11-29T05:00:00Z", "2011-01-29T04:59:59Z", "2017-06-08T13:21:26Z", "2010-29820", 0, 0, "0900006480ba7c1d"], ["FDA-2007-D-0150-0008", "FDA", "FDA-2007-D-0150", "Guidance for Industry on Antibacterial Drug Products: Use of Noninferiority Studies to Support Approval", "Notice", "Notice of Availability", "2010-11-29T05:00:00Z", 2010, 11, "2010-11-29T05:00:00Z", null, "2020-05-06T02:18:14Z", "2010-29796", 0, 0, "0900006480ba7bbf"], ["FDA-2010-D-0590-0001", "FDA", "FDA-2010-D-0590", "Guidance for Industry and Food and Drug Administration Staff; Availability, etc.: Blood Lancet Labeling", "Notice", "NAD-Notice of Availability of Data", "2010-11-29T05:00:00Z", 2010, 11, "2010-11-29T05:00:00Z", null, "2010-11-30T15:02:35Z", "2010-29795", 0, 0, "0900006480ba7c33"], ["FDA-2010-M-0361-0002", "FDA", "FDA-2010-M-0361", "Medical Devices; Availabilty of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "NAL-Notice of Approval", "2010-11-29T05:00:00Z", 2010, 11, "2010-11-29T05:00:00Z", null, "2010-11-29T15:04:46Z", "2010-29731", 0, 0, "0900006480ba7e6f"], ["FDA-2010-D-0565-0001", "FDA", "FDA-2010-D-0565", "Draft Guidance for Industry and Food and Drug Administration Staff; Availability, etc.: Establishing Performance Characteristics of In Vitro Diagnostic Devices for Detection of Clostridium difficile", "Notice", "NAD-Notice of Availability of Data", "2010-11-29T05:00:00Z", 2010, 11, "2010-11-29T05:00:00Z", "2011-03-01T04:59:59Z", "2010-11-29T20:19:53Z", "2010-29794", 0, 0, "0900006480ba8169"], ["FDA-2010-D-0584-0001", "FDA", "FDA-2010-D-0584", "Guidance for Industry on Abbreviated New Drug Applications; Availability: Impurities in Drug Products", "Notice", "Notice of Availability", "2010-11-29T05:00:00Z", 2010, 11, "2010-11-29T05:00:00Z", null, "2020-05-05T20:23:44Z", "2010-29896", 0, 0, "0900006480ba7cc3"], ["FDA-2010-N-0547-0001", "FDA", "FDA-2010-N-0547", "Clinical Development Programs for Sedation Products; Request for Assistance", "Notice", "N-Notice", "2010-11-29T05:00:00Z", 2010, 11, "2010-11-29T05:00:00Z", "2011-01-29T04:59:59Z", "2024-11-07T22:28:43Z", "2010-29927", 1, 0, "0900006480ba8187"], ["FDA-2010-N-0601-0001", "FDA", "FDA-2010-N-0601", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Current Good Manufacturing Practice Regulations for Medicated Feeds", "Notice", "60 Day Proposed Information Collection", "2010-11-29T05:00:00Z", 2010, 11, "2010-11-29T05:00:00Z", "2011-01-29T04:59:59Z", "2024-11-07T22:28:33Z", "2010-29928", 1, 0, "0900006480ba7ce7"]], "truncated": false, "filtered_table_rows_count": 797, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2010"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010", "results": [{"value": "FDA", "label": "FDA", "count": 797, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2010", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010", "results": [{"value": "Notice", "label": "Notice", "count": 797, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010", "results": [{"value": 2010, "label": 2010, "count": 797, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010&_facet_date=last_modified"}], "next": "2010-11-29T05~3A00~3A00Z,FDA-2010-N-0601-0001", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2010&_next=2010-11-29T05~3A00~3A00Z%2CFDA-2010-N-0601-0001&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 464.53066216781735, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}